22 May 2013
Keywords: Elan, EDT, Alkermes, Share sale, Roche, Illumina, FTC, Antitrust
Article | 14 March 2012
Ireland-based Elan Corp (NYSE: ELN) revealed yesterday that it has raised around $381 million in net proceeds from the sale of 76% (24.15 ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
14 March 2012
© 2013 thepharmaletter.com